[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Antiviral Nanocoatings Market, Global Outlook and Forecast 2022-2028

June 2022 | 123 pages | ID: A1492964E1E4EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Antiviral Nanocoatings in global, including the following market information:

Global Antiviral Nanocoatings Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Antiviral Nanocoatings Market Sales, 2017-2022, 2023-2028, (Tons)

Global top five Antiviral Nanocoatings companies in 2021 (%)

The global Antiviral Nanocoatings market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Metal Nanoparticles Coatings Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antiviral Nanocoatings include EnvisionSQ, Fusion Bionic, Bio-Fence, GrapheneCA, HeiQ Materials, Kastus, Nanoveu, NitroPep and Advanced Materials - JTJ s.r.o., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiviral Nanocoatings manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiviral Nanocoatings Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antiviral Nanocoatings Market Segment Percentages, by Type, 2021 (%)
  • Metal Nanoparticles Coatings
  • Carbon Nanotubes Coatings
  • Metal Oxide Nanoparticles Coatings
  • Graphene-based Coatings
Global Antiviral Nanocoatings Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antiviral Nanocoatings Market Segment Percentages, by Application, 2021 (%)
  • Achitechive
  • Medical Insurance
  • Textile Industry
  • Packaging Industry
  • Others
Global Antiviral Nanocoatings Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antiviral Nanocoatings Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antiviral Nanocoatings revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antiviral Nanocoatings revenues share in global market, 2021 (%)

Key companies Antiviral Nanocoatings sales in global market, 2017-2022 (Estimated), (Tons)

Key companies Antiviral Nanocoatings sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • EnvisionSQ
  • Fusion Bionic
  • Bio-Fence
  • GrapheneCA
  • HeiQ Materials
  • Kastus
  • Nanoveu
  • NitroPep
  • Advanced Materials - JTJ s.r.o.
  • Bio-Gate AG
  • Covalon Technologies Ltd.
  • Nano Came Co. Ltd.
  • Green Earth Nano Science
  • Halomine
  • Integrate
  • myNano
  • NanoTouch Materials
  • NBD Nanotechnologies
  • OrganoClick
  • Reactive Surfaces
  • Spartha Medical SAS
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antiviral Nanocoatings Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antiviral Nanocoatings Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIVIRAL NANOCOATINGS OVERALL MARKET SIZE

2.1 Global Antiviral Nanocoatings Market Size: 2021 VS 2028
2.2 Global Antiviral Nanocoatings Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antiviral Nanocoatings Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Antiviral Nanocoatings Players in Global Market
3.2 Top Global Antiviral Nanocoatings Companies Ranked by Revenue
3.3 Global Antiviral Nanocoatings Revenue by Companies
3.4 Global Antiviral Nanocoatings Sales by Companies
3.5 Global Antiviral Nanocoatings Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antiviral Nanocoatings Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antiviral Nanocoatings Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antiviral Nanocoatings Players in Global Market
  3.8.1 List of Global Tier 1 Antiviral Nanocoatings Companies
  3.8.2 List of Global Tier 2 and Tier 3 Antiviral Nanocoatings Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antiviral Nanocoatings Market Size Markets, 2021 & 2028
  4.1.2 Metal Nanoparticles Coatings
  4.1.3 Carbon Nanotubes Coatings
  4.1.4 Metal Oxide Nanoparticles Coatings
  4.1.5 Graphene-based Coatings
4.2 By Type - Global Antiviral Nanocoatings Revenue & Forecasts
  4.2.1 By Type - Global Antiviral Nanocoatings Revenue, 2017-2022
  4.2.2 By Type - Global Antiviral Nanocoatings Revenue, 2023-2028
  4.2.3 By Type - Global Antiviral Nanocoatings Revenue Market Share, 2017-2028
4.3 By Type - Global Antiviral Nanocoatings Sales & Forecasts
  4.3.1 By Type - Global Antiviral Nanocoatings Sales, 2017-2022
  4.3.2 By Type - Global Antiviral Nanocoatings Sales, 2023-2028
  4.3.3 By Type - Global Antiviral Nanocoatings Sales Market Share, 2017-2028
4.4 By Type - Global Antiviral Nanocoatings Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antiviral Nanocoatings Market Size, 2021 & 2028
  5.1.2 Achitechive
  5.1.3 Medical Insurance
  5.1.4 Textile Industry
  5.1.5 Packaging Industry
  5.1.6 Others
5.2 By Application - Global Antiviral Nanocoatings Revenue & Forecasts
  5.2.1 By Application - Global Antiviral Nanocoatings Revenue, 2017-2022
  5.2.2 By Application - Global Antiviral Nanocoatings Revenue, 2023-2028
  5.2.3 By Application - Global Antiviral Nanocoatings Revenue Market Share, 2017-2028
5.3 By Application - Global Antiviral Nanocoatings Sales & Forecasts
  5.3.1 By Application - Global Antiviral Nanocoatings Sales, 2017-2022
  5.3.2 By Application - Global Antiviral Nanocoatings Sales, 2023-2028
  5.3.3 By Application - Global Antiviral Nanocoatings Sales Market Share, 2017-2028
5.4 By Application - Global Antiviral Nanocoatings Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antiviral Nanocoatings Market Size, 2021 & 2028
6.2 By Region - Global Antiviral Nanocoatings Revenue & Forecasts
  6.2.1 By Region - Global Antiviral Nanocoatings Revenue, 2017-2022
  6.2.2 By Region - Global Antiviral Nanocoatings Revenue, 2023-2028
  6.2.3 By Region - Global Antiviral Nanocoatings Revenue Market Share, 2017-2028
6.3 By Region - Global Antiviral Nanocoatings Sales & Forecasts
  6.3.1 By Region - Global Antiviral Nanocoatings Sales, 2017-2022
  6.3.2 By Region - Global Antiviral Nanocoatings Sales, 2023-2028
  6.3.3 By Region - Global Antiviral Nanocoatings Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Antiviral Nanocoatings Revenue, 2017-2028
  6.4.2 By Country - North America Antiviral Nanocoatings Sales, 2017-2028
  6.4.3 US Antiviral Nanocoatings Market Size, 2017-2028
  6.4.4 Canada Antiviral Nanocoatings Market Size, 2017-2028
  6.4.5 Mexico Antiviral Nanocoatings Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Antiviral Nanocoatings Revenue, 2017-2028
  6.5.2 By Country - Europe Antiviral Nanocoatings Sales, 2017-2028
  6.5.3 Germany Antiviral Nanocoatings Market Size, 2017-2028
  6.5.4 France Antiviral Nanocoatings Market Size, 2017-2028
  6.5.5 U.K. Antiviral Nanocoatings Market Size, 2017-2028
  6.5.6 Italy Antiviral Nanocoatings Market Size, 2017-2028
  6.5.7 Russia Antiviral Nanocoatings Market Size, 2017-2028
  6.5.8 Nordic Countries Antiviral Nanocoatings Market Size, 2017-2028
  6.5.9 Benelux Antiviral Nanocoatings Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Antiviral Nanocoatings Revenue, 2017-2028
  6.6.2 By Region - Asia Antiviral Nanocoatings Sales, 2017-2028
  6.6.3 China Antiviral Nanocoatings Market Size, 2017-2028
  6.6.4 Japan Antiviral Nanocoatings Market Size, 2017-2028
  6.6.5 South Korea Antiviral Nanocoatings Market Size, 2017-2028
  6.6.6 Southeast Asia Antiviral Nanocoatings Market Size, 2017-2028
  6.6.7 India Antiviral Nanocoatings Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Antiviral Nanocoatings Revenue, 2017-2028
  6.7.2 By Country - South America Antiviral Nanocoatings Sales, 2017-2028
  6.7.3 Brazil Antiviral Nanocoatings Market Size, 2017-2028
  6.7.4 Argentina Antiviral Nanocoatings Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Antiviral Nanocoatings Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Antiviral Nanocoatings Sales, 2017-2028
  6.8.3 Turkey Antiviral Nanocoatings Market Size, 2017-2028
  6.8.4 Israel Antiviral Nanocoatings Market Size, 2017-2028
  6.8.5 Saudi Arabia Antiviral Nanocoatings Market Size, 2017-2028
  6.8.6 UAE Antiviral Nanocoatings Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 EnvisionSQ
  7.1.1 EnvisionSQ Corporate Summary
  7.1.2 EnvisionSQ Business Overview
  7.1.3 EnvisionSQ Antiviral Nanocoatings Major Product Offerings
  7.1.4 EnvisionSQ Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.1.5 EnvisionSQ Key News
7.2 Fusion Bionic
  7.2.1 Fusion Bionic Corporate Summary
  7.2.2 Fusion Bionic Business Overview
  7.2.3 Fusion Bionic Antiviral Nanocoatings Major Product Offerings
  7.2.4 Fusion Bionic Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.2.5 Fusion Bionic Key News
7.3 Bio-Fence
  7.3.1 Bio-Fence Corporate Summary
  7.3.2 Bio-Fence Business Overview
  7.3.3 Bio-Fence Antiviral Nanocoatings Major Product Offerings
  7.3.4 Bio-Fence Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.3.5 Bio-Fence Key News
7.4 GrapheneCA
  7.4.1 GrapheneCA Corporate Summary
  7.4.2 GrapheneCA Business Overview
  7.4.3 GrapheneCA Antiviral Nanocoatings Major Product Offerings
  7.4.4 GrapheneCA Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.4.5 GrapheneCA Key News
7.5 HeiQ Materials
  7.5.1 HeiQ Materials Corporate Summary
  7.5.2 HeiQ Materials Business Overview
  7.5.3 HeiQ Materials Antiviral Nanocoatings Major Product Offerings
  7.5.4 HeiQ Materials Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.5.5 HeiQ Materials Key News
7.6 Kastus
  7.6.1 Kastus Corporate Summary
  7.6.2 Kastus Business Overview
  7.6.3 Kastus Antiviral Nanocoatings Major Product Offerings
  7.6.4 Kastus Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.6.5 Kastus Key News
7.7 Nanoveu
  7.7.1 Nanoveu Corporate Summary
  7.7.2 Nanoveu Business Overview
  7.7.3 Nanoveu Antiviral Nanocoatings Major Product Offerings
  7.7.4 Nanoveu Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.7.5 Nanoveu Key News
7.8 NitroPep
  7.8.1 NitroPep Corporate Summary
  7.8.2 NitroPep Business Overview
  7.8.3 NitroPep Antiviral Nanocoatings Major Product Offerings
  7.8.4 NitroPep Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.8.5 NitroPep Key News
7.9 Advanced Materials - JTJ s.r.o.
  7.9.1 Advanced Materials - JTJ s.r.o. Corporate Summary
  7.9.2 Advanced Materials - JTJ s.r.o. Business Overview
  7.9.3 Advanced Materials - JTJ s.r.o. Antiviral Nanocoatings Major Product Offerings
  7.9.4 Advanced Materials - JTJ s.r.o. Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.9.5 Advanced Materials - JTJ s.r.o. Key News
7.10 Bio-Gate AG
  7.10.1 Bio-Gate AG Corporate Summary
  7.10.2 Bio-Gate AG Business Overview
  7.10.3 Bio-Gate AG Antiviral Nanocoatings Major Product Offerings
  7.10.4 Bio-Gate AG Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.10.5 Bio-Gate AG Key News
7.11 Covalon Technologies Ltd.
  7.11.1 Covalon Technologies Ltd. Corporate Summary
  7.11.2 Covalon Technologies Ltd. Antiviral Nanocoatings Business Overview
  7.11.3 Covalon Technologies Ltd. Antiviral Nanocoatings Major Product Offerings
  7.11.4 Covalon Technologies Ltd. Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.11.5 Covalon Technologies Ltd. Key News
7.12 Nano Came Co. Ltd.
  7.12.1 Nano Came Co. Ltd. Corporate Summary
  7.12.2 Nano Came Co. Ltd. Antiviral Nanocoatings Business Overview
  7.12.3 Nano Came Co. Ltd. Antiviral Nanocoatings Major Product Offerings
  7.12.4 Nano Came Co. Ltd. Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.12.5 Nano Came Co. Ltd. Key News
7.13 Green Earth Nano Science
  7.13.1 Green Earth Nano Science Corporate Summary
  7.13.2 Green Earth Nano Science Antiviral Nanocoatings Business Overview
  7.13.3 Green Earth Nano Science Antiviral Nanocoatings Major Product Offerings
  7.13.4 Green Earth Nano Science Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.13.5 Green Earth Nano Science Key News
7.14 Halomine
  7.14.1 Halomine Corporate Summary
  7.14.2 Halomine Business Overview
  7.14.3 Halomine Antiviral Nanocoatings Major Product Offerings
  7.14.4 Halomine Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.14.5 Halomine Key News
7.15 Integrate
  7.15.1 Integrate Corporate Summary
  7.15.2 Integrate Business Overview
  7.15.3 Integrate Antiviral Nanocoatings Major Product Offerings
  7.15.4 Integrate Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.15.5 Integrate Key News
7.16 myNano
  7.16.1 myNano Corporate Summary
  7.16.2 myNano Business Overview
  7.16.3 myNano Antiviral Nanocoatings Major Product Offerings
  7.16.4 myNano Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.16.5 myNano Key News
7.17 NanoTouch Materials
  7.17.1 NanoTouch Materials Corporate Summary
  7.17.2 NanoTouch Materials Business Overview
  7.17.3 NanoTouch Materials Antiviral Nanocoatings Major Product Offerings
  7.17.4 NanoTouch Materials Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.17.5 NanoTouch Materials Key News
7.18 NBD Nanotechnologies
  7.18.1 NBD Nanotechnologies Corporate Summary
  7.18.2 NBD Nanotechnologies Business Overview
  7.18.3 NBD Nanotechnologies Antiviral Nanocoatings Major Product Offerings
  7.18.4 NBD Nanotechnologies Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.18.5 NBD Nanotechnologies Key News
7.19 OrganoClick
  7.19.1 OrganoClick Corporate Summary
  7.19.2 OrganoClick Business Overview
  7.19.3 OrganoClick Antiviral Nanocoatings Major Product Offerings
  7.19.4 OrganoClick Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.19.5 OrganoClick Key News
7.20 Reactive Surfaces
  7.20.1 Reactive Surfaces Corporate Summary
  7.20.2 Reactive Surfaces Business Overview
  7.20.3 Reactive Surfaces Antiviral Nanocoatings Major Product Offerings
  7.20.4 Reactive Surfaces Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.20.5 Reactive Surfaces Key News
7.21 Spartha Medical SAS
  7.21.1 Spartha Medical SAS Corporate Summary
  7.21.2 Spartha Medical SAS Business Overview
  7.21.3 Spartha Medical SAS Antiviral Nanocoatings Major Product Offerings
  7.21.4 Spartha Medical SAS Antiviral Nanocoatings Sales and Revenue in Global (2017-2022)
  7.21.5 Spartha Medical SAS Key News

8 GLOBAL ANTIVIRAL NANOCOATINGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Antiviral Nanocoatings Production Capacity, 2017-2028
8.2 Antiviral Nanocoatings Production Capacity of Key Manufacturers in Global Market
8.3 Global Antiviral Nanocoatings Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTIVIRAL NANOCOATINGS SUPPLY CHAIN ANALYSIS

10.1 Antiviral Nanocoatings Industry Value Chain
10.2 Antiviral Nanocoatings Upstream Market
10.3 Antiviral Nanocoatings Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Antiviral Nanocoatings Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Antiviral Nanocoatings in Global Market
Table 2. Top Antiviral Nanocoatings Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antiviral Nanocoatings Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antiviral Nanocoatings Revenue Share by Companies, 2017-2022
Table 5. Global Antiviral Nanocoatings Sales by Companies, (Tons), 2017-2022
Table 6. Global Antiviral Nanocoatings Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antiviral Nanocoatings Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Antiviral Nanocoatings Product Type
Table 9. List of Global Tier 1 Antiviral Nanocoatings Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiviral Nanocoatings Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antiviral Nanocoatings Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antiviral Nanocoatings Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antiviral Nanocoatings Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antiviral Nanocoatings Sales (Tons), 2017-2022
Table 15. By Type - Global Antiviral Nanocoatings Sales (Tons), 2023-2028
Table 16. By Application – Global Antiviral Nanocoatings Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antiviral Nanocoatings Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antiviral Nanocoatings Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antiviral Nanocoatings Sales (Tons), 2017-2022
Table 20. By Application - Global Antiviral Nanocoatings Sales (Tons), 2023-2028
Table 21. By Region – Global Antiviral Nanocoatings Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antiviral Nanocoatings Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antiviral Nanocoatings Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antiviral Nanocoatings Sales (Tons), 2017-2022
Table 25. By Region - Global Antiviral Nanocoatings Sales (Tons), 2023-2028
Table 26. By Country - North America Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antiviral Nanocoatings Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antiviral Nanocoatings Sales, (Tons), 2017-2022
Table 29. By Country - North America Antiviral Nanocoatings Sales, (Tons), 2023-2028
Table 30. By Country - Europe Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antiviral Nanocoatings Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antiviral Nanocoatings Sales, (Tons), 2017-2022
Table 33. By Country - Europe Antiviral Nanocoatings Sales, (Tons), 2023-2028
Table 34. By Region - Asia Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antiviral Nanocoatings Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antiviral Nanocoatings Sales, (Tons), 2017-2022
Table 37. By Region - Asia Antiviral Nanocoatings Sales, (Tons), 2023-2028
Table 38. By Country - South America Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antiviral Nanocoatings Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antiviral Nanocoatings Sales, (Tons), 2017-2022
Table 41. By Country - South America Antiviral Nanocoatings Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antiviral Nanocoatings Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antiviral Nanocoatings Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Antiviral Nanocoatings Sales, (Tons), 2023-2028
Table 46. EnvisionSQ Corporate Summary
Table 47. EnvisionSQ Antiviral Nanocoatings Product Offerings
Table 48. EnvisionSQ Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Fusion Bionic Corporate Summary
Table 50. Fusion Bionic Antiviral Nanocoatings Product Offerings
Table 51. Fusion Bionic Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Bio-Fence Corporate Summary
Table 53. Bio-Fence Antiviral Nanocoatings Product Offerings
Table 54. Bio-Fence Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. GrapheneCA Corporate Summary
Table 56. GrapheneCA Antiviral Nanocoatings Product Offerings
Table 57. GrapheneCA Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. HeiQ Materials Corporate Summary
Table 59. HeiQ Materials Antiviral Nanocoatings Product Offerings
Table 60. HeiQ Materials Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Kastus Corporate Summary
Table 62. Kastus Antiviral Nanocoatings Product Offerings
Table 63. Kastus Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. Nanoveu Corporate Summary
Table 65. Nanoveu Antiviral Nanocoatings Product Offerings
Table 66. Nanoveu Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. NitroPep Corporate Summary
Table 68. NitroPep Antiviral Nanocoatings Product Offerings
Table 69. NitroPep Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 70. Advanced Materials - JTJ s.r.o. Corporate Summary
Table 71. Advanced Materials - JTJ s.r.o. Antiviral Nanocoatings Product Offerings
Table 72. Advanced Materials - JTJ s.r.o. Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 73. Bio-Gate AG Corporate Summary
Table 74. Bio-Gate AG Antiviral Nanocoatings Product Offerings
Table 75. Bio-Gate AG Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 76. Covalon Technologies Ltd. Corporate Summary
Table 77. Covalon Technologies Ltd. Antiviral Nanocoatings Product Offerings
Table 78. Covalon Technologies Ltd. Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 79. Nano Came Co. Ltd. Corporate Summary
Table 80. Nano Came Co. Ltd. Antiviral Nanocoatings Product Offerings
Table 81. Nano Came Co. Ltd. Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 82. Green Earth Nano Science Corporate Summary
Table 83. Green Earth Nano Science Antiviral Nanocoatings Product Offerings
Table 84. Green Earth Nano Science Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 85. Halomine Corporate Summary
Table 86. Halomine Antiviral Nanocoatings Product Offerings
Table 87. Halomine Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 88. Integrate Corporate Summary
Table 89. Integrate Antiviral Nanocoatings Product Offerings
Table 90. Integrate Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 91. myNano Corporate Summary
Table 92. myNano Antiviral Nanocoatings Product Offerings
Table 93. myNano Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 94. NanoTouch Materials Corporate Summary
Table 95. NanoTouch Materials Antiviral Nanocoatings Product Offerings
Table 96. NanoTouch Materials Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 97. NBD Nanotechnologies Corporate Summary
Table 98. NBD Nanotechnologies Antiviral Nanocoatings Product Offerings
Table 99. NBD Nanotechnologies Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 100. OrganoClick Corporate Summary
Table 101. OrganoClick Antiviral Nanocoatings Product Offerings
Table 102. OrganoClick Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 103. Reactive Surfaces Corporate Summary
Table 104. Reactive Surfaces Antiviral Nanocoatings Product Offerings
Table 105. Reactive Surfaces Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 106. Spartha Medical SAS Corporate Summary
Table 107. Spartha Medical SAS Antiviral Nanocoatings Product Offerings
Table 108. Spartha Medical SAS Antiviral Nanocoatings Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 109. Antiviral Nanocoatings Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 110. Global Antiviral Nanocoatings Capacity Market Share of Key Manufacturers, 2020-2022
Table 111. Global Antiviral Nanocoatings Production by Region, 2017-2022 (Tons)
Table 112. Global Antiviral Nanocoatings Production by Region, 2023-2028 (Tons)
Table 113. Antiviral Nanocoatings Market Opportunities & Trends in Global Market
Table 114. Antiviral Nanocoatings Market Drivers in Global Market
Table 115. Antiviral Nanocoatings Market Restraints in Global Market
Table 116. Antiviral Nanocoatings Raw Materials
Table 117. Antiviral Nanocoatings Raw Materials Suppliers in Global Market
Table 118. Typical Antiviral Nanocoatings Downstream
Table 119. Antiviral Nanocoatings Downstream Clients in Global Market
Table 120. Antiviral Nanocoatings Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Antiviral Nanocoatings Segment by Type
Figure 2. Antiviral Nanocoatings Segment by Application
Figure 3. Global Antiviral Nanocoatings Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antiviral Nanocoatings Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antiviral Nanocoatings Revenue, 2017-2028 (US$, Mn)
Figure 7. Antiviral Nanocoatings Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Antiviral Nanocoatings Revenue in 2021
Figure 9. By Type - Global Antiviral Nanocoatings Sales Market Share, 2017-2028
Figure 10. By Type - Global Antiviral Nanocoatings Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antiviral Nanocoatings Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Antiviral Nanocoatings Sales Market Share, 2017-2028
Figure 13. By Application - Global Antiviral Nanocoatings Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antiviral Nanocoatings Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Antiviral Nanocoatings Sales Market Share, 2017-2028
Figure 16. By Region - Global Antiviral Nanocoatings Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antiviral Nanocoatings Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antiviral Nanocoatings Sales Market Share, 2017-2028
Figure 19. US Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antiviral Nanocoatings Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antiviral Nanocoatings Sales Market Share, 2017-2028
Figure 24. Germany Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 25. France Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antiviral Nanocoatings Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antiviral Nanocoatings Sales Market Share, 2017-2028
Figure 33. China Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 37. India Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antiviral Nanocoatings Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antiviral Nanocoatings Sales Market Share, 2017-2028
Figure 40. Brazil Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antiviral Nanocoatings Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antiviral Nanocoatings Sales Market Share, 2017-2028
Figure 44. Turkey Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antiviral Nanocoatings Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antiviral Nanocoatings Production Capacity (Tons), 2017-2028
Figure 49. The Percentage of Production Antiviral Nanocoatings by Region, 2021 VS 2028
Figure 50. Antiviral Nanocoatings Industry Value Chain
Figure 51. Marketing Channels


More Publications